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Edited by Laszlo NagyAbstract Serine protease inhibitor SerpinE2 is known as a
cytokine-inducible gene. Here, we investigated whether tumor
necrosis factor a-(TNF-a)-induced expression of SerpinE2 is
mediated by the nuclear factor-jB (NF-jB) p65 subunit. Both
steady state and TNF-a-induced expression of SerpinE2 mRNA
were abrogated in p65/ murine embryonic ﬁbroblasts (MEFs).
Reconstitution with wild-type p65 rescued SerpinE2 mRNA
expression in an IjB kinase b-dependent manner. Electrophore-
sis mobility shift assay and ChIP assay demonstrated that p65
bound to the jB-like DNA sequence located at approximately
9 kbp in the SerpinE2 promoter. In addition, TNF-a stimu-
lated luciferase gene expression driven by the jB-like element
in the reconstituted MEFs, but not in p65/ MEFs. These re-
sults indicated that activation of NF-jB p65 plays an important
role in TNF-a-induced expression of SerpinE2.
 2006 Federation of European Biochemical Societies. Published
by Elsevier B.V. All rights reserved.
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inhibitor, clade E, member 2; Tumor necrosis factor a; Murine
embryonic ﬁbroblast1. Introduction
The transcription factor nuclear factor-jB (NF-jB) plays a
central role in regulating inﬂammatory, immune, and anti-
apoptotic responses [1–6]. NF-jB is composed of homo- and
heterodimers of Rel family proteins including p65/RelA, RelB,
c-Rel, p50/p105, and p52/p100. The prototypical complex cor-
responds to a heterodimer of p65 and p50 subunits. The IjB
kinase (IKK) complex, composed of two catalytic subunits
(IKKa and IKKb) [7–12] and the scaﬀolding protein IKKc/
NEMO [13,14], is recruited to tumor necrosis factor a (TNF-
a) receptor complexes, which in turn triggers phosphorylation
of IjB. The phosphorylated form of inhibitor of jB a (IjBa) is
rapidly degraded by a ubiquitin-proteasome system [7–12,15].Abbreviations: NF-jB, nuclear factor-jB; SerpinE2, serine protease
inhibitor, clade E, member 2; TNF-a, tumor necrosis factor a; IjBa,
inhibitor of jB a; IKKb, IjB kinase b
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doi:10.1016/j.febslet.2006.04.086The p65 subunit at Ser-468 and Ser-536 in the transactivation
domain is also phosphorylated by the IKK complex during the
process of IjBa’s degradation, although the cellular function
of this phosphorylation is still controversial. Stimulus-depen-
dent degradation of IjBa results in the translocation of NF-
jB into the nucleus, where it binds to speciﬁc binding sites
within the promoter of target genes.
The Serpin family of serine protease inhibitors have been
isolated as key molecules regulating several physiological func-
tions. Serine protease inhibitor, clade E, member 2 (SerpinE2),
also known as plasminogen activator inhibitor-2 (PAI-2) and
Protease Nexin-1 (PN-1), is a potent inhibitor of several serine
proteinases such as thrombin, urokinase-plasminogen activa-
tor (u-PA), and tissue-type-plasminogen activator (t-PA). Ser-
pinE2 is expressed in a variety of cells such as glial cells,
neurons, and ﬁbroblasts [16,17]. In addition, several reports
have shown that the expression of SerpinE2 is increased by
TNF-a, interleukin-1b (IL-1b), and transforming growth fac-
tor-b (TGF-b) [18,19]. However, its physiological function
and mechanism of expression remains to be characterized.
In this study, we have focused on the involvement ofNF-jB in
TNF-a-induced SerpinE2 gene expression using p65/ murine
embryonic ﬁbroblasts (MEFs).We found thatNF-jBp65 binds
to a jB-like element far upstream within its promoter and is
essential for TNF-a-induced SerpinE2 mRNA expression.2. Materials and methods
2.1. Antibodies and reagents
Antibodies against p65 (C-20-G), p50 (H-119), p52 (K-27), IjBa (C-
21), and PCNA (PC-10) were obtained from Santa Cruz Biotechnol-
ogy. Recombinant human TNF-a and SC-514 were purchased from
GenzymeTECHNE and Calbiochem, respectively.
2.2. Cell cultures and transfection
p65/ mouse embryonic ﬁbroblasts (MEFs) were mock transfected
or transfected with wild-type p65/RelA using a retroviral vector pMX-
puro and stable transfectants were selected with 2.5 lg/ml puromycin
(Sigma) [20,21]. MEFs were maintained in Dulbecco’s modiﬁed Eagle’s
medium (high glucose) supplemented with 10% FCS, 100 U/ml penicil-
lin, and 100 lg/ml streptomycin at 37 C in 5% CO2. B16/BL6 cells
were maintained in Eagle’s minimum essential medium supplemented
with 10% FCS, 100 U/ml penicillin, 100 lg/ml streptomycin, and L-glu-
tamine at 37 C in 5% CO2. Cells were transfected with expression
plasmids using LipofectAMINE and PLUS reagents (Invitrogen).blished by Elsevier B.V. All rights reserved.
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Cell lysates were resolved by SDS–PAGE and transferred to an
Immobilon-P nylon membrane (Millipore). The membrane was treated
with BlockAce (Dainippon Pharmaceutical Co. Ltd., Suita, Japan)
overnight at 4 C and probed with the primary antibodies as described
above. The antibodies were detected using horseradish peroxidase-con-
jugated anti-rabbit, anti-mouse, and anti-goat IgG (DAKO), and visu-
alized with the ECL system (Amersham Biosciences).
2.4. Northern blotting
Total RNA extracted fromMEFs was isolated using ISOGEN (Nip-
pongene). RNA samples (10 lg) were size-fractionated on a denaturing
formaldehyde agarose gel, transferred capillarity to a nylon membrane
(Hybond-N+, Amersham Biosciences), and UV-cross-linked. The
membranes were hybridized with 32P-labeled DNA probes synthesized
using mouse SerpinE2 or GAPDH cDNAs as templates.
2.5. Real-time PCR
Total RNA was prepared using an RNeasyMini kit (QIAGEN). The
ﬁrst strand cDNAs were synthesized by SuperScript II reverse trans-
criptase (Invitrogen). The cDNAs were ampliﬁed quantitatively using
SYBRGreen PCRmix (TaKaRa). The sequences for primers are as fol-
lows: SerpinE2 (forward: 5 0-ACATAGAAACGGACATTCGTGGCA
GGTGAT-30 and reverse: 5 0-TAGTGATGTGAGGGATGATGG-
CAGACAGT-3 0) and GAPDH (forward: 5 0-GGTGAAGGTCGGTG
TGAACGGATTT-3 0 and reverse: 5 0-GATGCCAAAGTTGTCATG-
GATGACC-30). Real-time quantitative RT-PCR was performed using
an ABI Prism 7300 sequence detection system (Applied Biosystems,
USA). All data were normalized to GAPDH mRNA.
2.6. Electrophoresis mobility shift assay
Nuclear extracts were prepared from MEFs after stimulation as de-
scribed previously [22] and probed with 32P-labeled high-homology
DNA sequences for the consensus jB-site in the SerpinE2 promoter
(named jB-like-1–7). The protein–DNA complexes were separated
on a 4% polyacrylamide gel by electrophoresis as described previously
[22]. A Super shift assay was executed using nuclear extracts pretreated
with antibodies against the Rel family proteins.
2.7. Chromatin immunoprecipitation assay
The chromatin immunoprecipitation (ChIP) analysis was performed
according to a protocol provided by Upstate Biotechnology with min-
or modiﬁcations. After stimulation with TNF-a, MEFs were ﬁxed with
1% formaldehyde for 5 min. After the cells were lysed in SDS lysis buf-
fer, chromatin was sheared by sonication to an average size of approx-
imately 0.5–1 kb. Chromatin solutions were precipitated overnight at
4 C using anti-p65 antibody. Immunecomplexes were collected with
salmon sperm DNA-saturated protein G Sepharose for 3 h and washed
extensively. Immunoprecipitated chromatin was incubated at 65C
overnight to reverse the cross-link. After proteinase K digestion,
DNA was extracted with phenol/chloroform and precipitated with eth-
anol. Precipitated DNAs were ampliﬁed by PCR (33 cycles) using
KOD-Plus (TOYOBO) with primers to amplify a 227-bp fragment
of the mouse SerpinE2 promoter (9790/9573).
2.8. Reporter gene assay
Four tandem copies of the jB-like-2 sequence (GGGAATTCCC) or
its mutant (GGGAATTGAC) were linked to the proximal SerpinE2
promoter (251/+135) in pGL3(R2.1)-Basic vector (Promega). Cells
were cotransfected with the reporter plasmids and pRL-EF1a Renilla
luciferase plasmid (a kind gift from Dr. Masaaki Tsuda). The lucifer-
ase activity was measured by using the Dual-Luciferase reporter assay
kit (Promega). The activity was normalized on the basis of Renilla
luciferase activity.Fig. 1. Involvement of NF-jB p65 in SerpinE2 gene expression. (A)
MEFs were stimulated with 20 ng/ml TNF-a for the periods indicated.
Total RNA (10 lg) was separated on a denaturing formaldehyde
agarose gel, transferred to a nylon membrane, and hybridized with the
probe for SerpinE2. The ratios of a GAPDH normalized densitometry
value were shown in the bottom of blot. n.d. means ‘not determined’.
(B) MEFs were stimulated with 20 ng/ml TNF-a for 3 h. SerpinE2
mRNA levels were measured by real-time RT-PCR. The values
represent the means ± S.D. from triplicate determinations. *P < 0.01.3. Results
3.1. TNF-a-induced SerpinE2 mRNA expression in NF-jB
p65/ MEFs
It has been reported that TNF-a, IL-1b, and TGF-b induced
the expression and secretion of SerpinE2 [18,19]. However, themechanism of stimulus-dependent SerpinE2 gene expression
remains to be characterized. Here, we investigated whether
NF-jB p65 is involved in the expression of SerpinE2 mRNA
in p65/ MEFs stably transfected with wild-type p65 (p65-
MEFs) or mock transfected (mock-MEFs) using retroviral
vectors (Fig. 1). The protein expression level of p65 in stable
p65 transfectants (p65-MEFs) was almost equivalent to the
endogenous level in the wild-type MEFs [20]. Northern blot
analysis showed that the expression of SerpinE2 mRNA was
induced within 3 h after TNF-a treatment in p65-MEFs
(Fig. 1A). In contrast, both steady state and TNF-a-induced
expression of SerpinE2 mRNA were abrogated in mock-
MEFs. A similar result was obtained in the real-time RT-
PCR analysis, in which a lower level of SerpinE2 mRNA
expression was not induced by TNF-a in mock-MEFs
(Fig. 1B). These results indicated that NF-jB p65 has an
important role in TNF-a-induced SerpinE2 mRNA expres-
sion.
3.2. Nuclear translocation of NF-jB p65 in MEFs after TNF-a
treatment
We analyzed the nuclear localization of p65 and degradation
of IjBa after stimulation with TNF-a in p65-MEFs and mock-
MEFs. Stimulation of p65-MEFs induced the nuclear translo-
cation of p65 and degradation of IjBa, which induced de novo
synthesis of IjBa protein (Fig. 2A). This correlated with the
Fig. 2. Time course of p65 nuclear translocation and IjBa degradation. MEFs were stimulated with 20 ng/ml TNF-a for the periods indicated.
Nuclear or cytoplasmic extracts were immunoblotted with anti-p65, anti-IjBa and anti-PCNA antibodies. (B) MEFs were stimulated with TNF-a
for the indicated periods. Whole cell extracts were immunoblotted with phospho-speciﬁc and control antibodies against p65, p38 and JNK.
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although the degradation of IjBa was normal, nuclear
translocation of p65 and re-synthesis of IjBa was impaired in
mock-MEFs. On the other hand, the TNF-a-induced activa-
tion of c-Jun N-terminal kinase (JNK)/p38 mitogen-activated
protein kinases (MAPKs) was comparable in both MEFs
(Fig. 2B). These results conﬁrmed that functional NF-jB activ-
ity was recovered by reconstitution of p65 in p65/ MEFs.
3.3. Eﬀect of the IKK inhibitor SC-514 on TNF-a-induced
SerpinE2 gene expression
In the process of IjBa’s degradation, the stimulus-induced
phosphorylation of two NH2-terminal serine residues by the
IKK complex, especially IKKb, is essential. As shown in
Fig. 3A, SC-514, an IKKb-speciﬁc inhibitor [23], blocked both
the nuclear translocation of p65 and degradation of IjBa by
TNF-a in B16-BL6, a highly metastatic mouse melanoma cell
line. The induction of SerpinE2 mRNA expression by TNF-a
was also detected in this cell line (Fig. 3B). We next investi-
gated the eﬀect of the IKKb inhibitor on TNF-a-induced Ser-
pinE2 expression. Both the basal level and TNF-a-induced
expression of SerpinE2 mRNA were suppressed by SC-514
(Fig. 3B). These results indicate that the IKKb-mediated
canonical NF-jB pathway is essential for TNF-a-induced Ser-
pinE2 gene expression.
3.4. NF-jB p65-binding sites in the SerpinE2 promoter
The consensus DNA-binding sequence of NF-jB is
GGGRNNYYCC (N = any base, R = purine, and Y = pyrim-
idine) [24]. In the locus of the mouse SerpinE2 gene on chro-mosome 1, several DNA sequences highly homologous to the
consensus jB site were identiﬁed in the genome data base.
We focused on seven sequences located within 20 kbp up-
stream of the transcription start site of SerpinE2 (Fig. 4A).
First, we tried to investigate the NF-jB binding to these pro-
moter sequences by electrophoresis mobility shift assay
(EMSA) using oligonucleotide probes. TNF-a-induced
DNA-binding activity was detected only in the sequence lo-
cated at approximately 9 kbp in p65-MEFs (Fig. 4B). A
super shift assay demonstrated that at least NF-jB p65 is in-
cluded in the complex (Fig. 4C). In contrast, the DNA-binding
activity was largely abrogated in mock-MEFs (Fig. 4D). These
results indicated that TNF-a-induced expression of SerpinE2
might be regulated by p65 binding to the jB-like site located
at approximately 9 kbp.
3.5. Involvement of NF-jB p65 in the activation of the SerpinE2
promoter
We examined the association of NF-jB p65 with jB-like-2
in the SerpinE2 promoter in vivo. A ChIP assay showed that
the association of NF-jB p65 with this site was induced by
TNF-a treatment within 20 min. We next investigated the tran-
scriptional activation via jB-like-2 in a reporter gene assay. As
shown in Fig. 5B, the luciferase activity from the proximal pro-
moter of SerpinE2 (251/+135) was not induced. The insertion
of four tandem repeat of jB-like-2, but not the mutated site,
upstream of the proximal promoter induced TNF-a-mediated
luciferase activity in p65-MEFs. In contrast, no induction of
TNF-a-induced jB-like-2-driven luciferase gene expression
was detected in mock-MEFs (Fig. 5C). These results demon-
Fig. 3. Eﬀect of the IKK inhibitor SC-514 on SerpinE2 gene
expression. (A) B16-BL6 cells were pretreated with 100 lM SC-514
for 30 min. Cells were stimulated with 20 ng/ml TNF-a for 10 min.
Nuclear or cyotoplasmic extracts were immunoblotted with anti-p65
and anti-IjBa antibodies. (B) B16-BL6 cells were pretreated with
100 lM SC-514 for 30 min, and then stimulated with 20 ng/ml TNF-a
for 18 h. SerpinE2 mRNA levels were measured by real-time RT-PCR.
The values represent the means ± S.D. from triplicate determinations.
*P < 0.01.
Fig. 4. Identiﬁcation of NF-jB-binding sites in the SerpinE2 pro-
moter. (A) The sequences and location of jB-like sites in the mouse
SerpinE2 promoter. (B–D) Each MEF was stimulated with TNF-a for
10 min. An EMSA was carried out using 32P-labeled oligonucleotide
probes containing each jB-like site. (C) Nuclear extracts from TNF-a-
treated MEFs were pretreated with each antibody against Rel family
proteins.
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scriptional regulation of the SerpinE2 promoter.4. Discussion
A number of studies in vivo have assessed whether SerpinE2
expression regulates the metastatic potential of cancer of the
neck, lung, breast, and pancreas [25–28]. SerpinE2, for exam-
ple, promotes production of the extracellular matrix and local
invasion by pancreatic tumors [28]. In contrast, overexpression
of SerpinE2 in melanoma cells prevented spontaneous metas-
tasis of transplanted cells in scid mice [29]. In addition, it has
been reported that SerpinE2 is involved in several pathogenic
conditions, including viral infections, the formation of papillo-
mas in the skin, the inhibition of apoptosis, and chronic
obstructive pulmonary disease. These ﬁndings indicate that a
study of the regulatory mechanisms of SerpinE2 gene expres-
sion will provide information on its pathophysiological impor-
tance in these diseases. In this study, we have shown that NF-
jB, one of the major transcription factors involved in these
diseases, regulates SerpinE2 gene expression under basal and
TNF-a-stimulated conditions.
It is evident that the SerpinE2 gene expression can be induced
by a wide range of stimulants, including TNF-a, IL-1/-2, TGF-
b and epidermal growth factor [18,19,30]. Past analyses of thehuman promoter indicate that SerpinE2 gene expression is reg-
ulated by AP-1-like elements, a cAMP responsive element
(CRE)-like element, and Sp1-binding sites in the proximal pro-
moter region [31–33]. Furthermore, it has been reported that
there is an NF-jB-like motif located at 400 bp, which regu-
lates the basal, but not TNF-a-induced, SerpinE2 promoter
activity [34]. This is correlated with our result that TNF-a did
not induce the DNA-binding activity of the jB-like-6 element
located at 429 bp in the mouse proximal promoter
(Fig. 4B). We also demonstrated that wild-type p65 induced
the SerpinE2 gene expression under the basal condition
(Fig. 1A). These observations suggest that p65-binding to the
proximal jB site controls the basal SerpinE2 gene expression.
In addition, we found several jB-like sites in a distal region
of the human SerpinE2 promoter in the genome database,
one of which located at approximately 9 kbp has a very sim-
ilar sequence (GGGAATTACC) to the distal jB-like element
in the mouse SerpinE2 promoter (jB-like-2; GGGAATTCCC).
Baidong et al. has demonstrated that NF-jB regulates TNF-a-
induced transcription of the human plasminogen activator inhib-
itor-1 (PAI-1) gene, a member of the serpin superfamily, by
binding to the jB-site located 14.5 kb from the transcription
start site [35]. Therefore, it is necessary to investigate the role of
NF-jB in the transcriptional regulation of human SerpinE2,
especially in a distal region of the promoter.
Fig. 5. Activation of the SerpinE2 promoter by NF-jB p65. (A) MEFs
were stimulated with 20 ng/ml TNF-a for the periods indicated, and
then ﬁxed with 1% formaldehyde for 5 min. Chromatin immunopre-
cipitation assay was performed with anti-p65 antibody. The associated
DNA was analyzed by PCR using SerpinE2 promoter-speciﬁc primers.
(B, C) MEFs were transfected with reporter plasmids linked to the
jB-like-2 or mutant site and pRL-EF1a control Renilla luciferase
plasmid. Twenty-four hours after transfection, cells were stimulated
with 20 ng/ml TNF-a for 4 h. Luciferase activities were determined
with the Dual-Luciferase reporter assay system. Data are the
means ± S.D. *P < 0.01.
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of p65 on serine 536 by IKK paralleled the activation of NF-
jB [36]. This site is located in the transactivation domain and
several reports have suggested the importance of the phos-
phorylation to the transcriptional activity of the p65 subunit.
However, a consensus has yet to be reached about the physio-
logical roles of the phosphorylation. We investigated the
involvement of Ser-536 phosphorylation in SerpinE2 gene
expression in p65/ MEFs reconstituted with the wild-type
or S536A mutant of human p65. However, the S536A mutant
induced jB-like-2-driven luciferase gene expression normally
(data not shown). This correlated with the observation that
TNF-a-induced production of IL-6 and apoptosis were not im-
paired in the S536A-MEFs [20]. Therefore, the phosphoryla-
tion of Ser-536 may not always be essential for inducible
transcriptional activity of the NF-jB p65 subunit.In summary, we have demonstrated that NF-jB p65 binds
to the jB-like site in the distal SerpinE2 promoter, and induces
its transcription. These ﬁndings provide for the possibility that
the TNF-a-induced activation of NF-jB mediates SerpinE2
expression in inﬂammation-induced progression of cancer.
We have recently developed a TNF-a-induced cancer metasta-
sis model in mouse colon cancer cells; therefore, we will try to
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